UK markets open in 3 hours 13 minutes
  • NIKKEI 225

    -232.89 (-0.83%)

    -409.18 (-2.05%)

    -0.36 (-0.40%)

    -4.40 (-0.24%)
  • DOW

    -58.09 (-0.18%)

    -869.48 (-4.39%)
  • CMC Crypto 200

    -25.95 (-4.66%)
  • ^IXIC

    -150.57 (-1.19%)
  • ^FTAS

    -3.43 (-0.08%)

Biobanking Market Report 2022-2032

·6-min read

Forecasts by Type (Standalone, Partnership), by Application (Regenerative Medicine, Life Science Research, Clinical Research), by Ownership (National/Regional, Universities, Non-Profit, Private), by Sample Type (Blood Products, Human Tissues, Nucleic Acids, Cell Lines, Biological Fluids, Other), by Product and Service (Equipment, Consumables, Services, Software) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Recovery Scenarios

New York, July 21, 2022 (GLOBE NEWSWIRE) -- announces the release of the report "Biobanking Market Report 2022-2032" -

The Biobanking Market Report 2022-2032: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

A biobank is a place where biological materials that are connected to clinical data are stored. These samples are collected, handled, kept, and processed in compliance with quality standards to benefit society in some kind of a non-profit manner and to promote biomedical research. Large collections of information and biological samples known as biobanks were built specifically for the study. In a number of industries, which would include pharma, academic institutions, livestock breeding, and charitable foundations, these repositories are essential again for advances in medical science into illnesses pathologies as well as demographically experiments within areas of epigenetic mechanisms, preventive services medical programs, chronic illnesses, and epidemiology. Tumor specimens, umbilical, blood, and cerebral spinal fluid are just a few of the several places where biospecimens can be found.

Biobanks Have Emerged Due to Enormous Growth in Scientific Production in Biomedicine During the Past Five Years

Biobanks have increased in size, number, and in some respects, speciation. Biospecimen source guides today include hundreds of biobanks, each with a unique business model for gathering, storing, disseminating, tagging, categorizing, and analyzing specimens (mostly originating from humans) for scientific study. The necessity to combine fundamental and clinical research by promoting cooperative models and the potential to boost informed consent effectiveness because the same genetic material may be used for different purposes led to the emergence of biobanks during the last five years.

What Questions Should You Ask before Buying a Market Research Report?
• How is the biobanking market evolving?
• What is driving and restraining the biobanking market?
• How will each biobanking submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2032?
• How will the market shares for each biobanking submarket develop from 2022 to 2032?
• What will be the main driver for the overall market from 2022 to 2032?
• Will leading biobanking markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2032 and which geographical region will lead the market in 2032?
• Who are the leading players and what are their prospects over the forecast period?
• What are the biobanking projects for these leading companies?
• How will the industry evolve during the period between 2020 and 2032? What are the implications of biobanking projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the biobanking market?
• Where is the biobanking market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the biobanking market today, and over the next 10 years:
• Our 553-page report provides 359 tables and 317 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains an in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the biobanking market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2032 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2032, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising biobanking prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

Segments Covered in the Report

Market Segment by Type
• Standalone
• Partnership

Market Segment by Application
• Regenerative Medicine
• Life Science Research
• Clinical Research

Market Segment by Ownership
• National/ Regional
• Universities
• Non-Profit
• Private

Market Segment by Sample Type
• Blood Products
• Human Tissues
• Nucleic Acids
• Cell Lines
• Biological Fluids
• Other Samples

Market Segment by Product and Service
• Equipment
• Consumables
• Services
• Software

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for four regional and 20 leading national markets:

North America
• U.S.
• Canada

• Germany
• UK
• France
• Italy
• Spain
• Russia
• Denmark
• Finland
• Rest of Europe

Asia Pacific
• China
• Japan
• India
• Singapore
• Australia
• Rest of Asia Pacific

• Brazil
• Qatar
• Saudi Arabia
• Egypt
• Mexico
• Rest of Latin America

The report also includes profiles and for some of the leading companies in the Biobanking Market, 2022 to 2032, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth
• AMS Biotechnology (Europe) Ltd.
• Avantor, Inc.
• Azenta, Inc. (Azenta)
• Bay Biosciences LLC
• Bioivt & Elevating Science
• Boca Biolistics
• CTI Biotech
• Cureline Inc.
• Firalis SA
• Geneticist Inc.
• Hamilton Bonaduz AG
• Isenet Biobanking
• Merck & Co., Inc.
• ProteoGenex Inc.
• Qiagen NV
• Stemcell Holdings, Inc.
• STEMCELL Technologies Inc.
• Thermo Fisher Scientific Inc.
• US Biolab Corp. Inc.

Overall world revenue for Biobanking Market, 2022 to 2032 in terms of value the market will surpass US$59,347 million in 2022, our work calculates. We predict strong revenue growth through to 2032. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Biobanking Market, 2022 to 2032 report help you?

In summary, our 550+ page report provides you with the following knowledge:
• Revenue forecasts to 2032 for Biobanking Market, 2022 to 2032 Market, with forecasts for type, application, sample type, ownership, product and service, and company size, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
• Revenue forecasts to 2032 for four regional and 20 key national markets – See forecasts for the Biobanking Market, 2022 to 2032 market in North America, Europe, Asia-Pacific and LAMEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market – including company profiles for 20 of the major companies involved in the Biobanking Market, 2022 to 2032.

Read the full report:

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.


CONTACT: Clare: US: (339)-368-6001 Intl: +1 339-368-6001

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting